Skip to content
  • Sunday, 26 July 2026
  • 2:48 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Rocket Pharmaceuticals Secures Landmark FDA Approval for Kresladi, Ushering in a New Era for Ultra-Rare Immune Disease Treatment
Pharmaceutical R&D

Rocket Pharmaceuticals Secures Landmark FDA Approval for Kresladi, Ushering in a New Era for Ultra-Rare Immune Disease Treatment

Teuku Ryan Mar 27, 2026 0

The U.S. Food and Drug Administration (FDA) has granted accelerated approval to Rocket Pharmaceuticals’ Kresladi (marnetegragene autotemcel), a groundbreaking gene…

Read More
Laboratory Automation & Robotics

Novo Nordisk’s new weight loss treatment inferior to Lilly’s tirzepatide

Lana Keisha Mar 26, 2026 0

Novo Nordisk’s latest investigational weight loss treatment, CagriSema, has failed to achieve its primary endpoint of demonstrating non-inferiority when compared…

Read More
Stem Cell & Regenerative Medicine

Identification of Fam102a as a Dual Regulator of Bone Remodeling Offers New Horizons for Osteoporosis Treatment

Dwi Wanna Mar 23, 2026 0

The landscape of regenerative medicine and orthopedics has been significantly advanced by the identification of Family with Sequence Similarity 102…

Read More
Stem Cell & Regenerative Medicine

HKUMed Researchers Identify Piezo1 Protein as Molecular Exercise Sensor Offering New Hope for Osteoporosis Treatment and Bone Health Maintenance

Dwi Wanna Mar 22, 2026 0

Researchers from the Department of Medicine at the School of Clinical Medicine, LKS Faculty of Medicine, University of Hong Kong…

Read More
Biotech & Genetic Research

First-of-its-Kind Implant Promises Dramatic Improvement for Severe Tissue Loss Treatment

Jia Lissa Mar 20, 2026 0

An international research consortium, spearheaded by the renowned Levenberg Laboratory at the Technion-Israel Institute of Technology, has unveiled a groundbreaking,…

Read More
Laboratory Automation & Robotics

First Phase 3 psilocybin data clears the bar for treatment-resistant depression, but how high was the bar?

Lana Keisha Mar 20, 2026 0

The landscape of mental health treatment witnessed a significant development on February 17, 2026, as Compass Pathways, a leading mental…

Read More
Neuroscience & Brain Research

Unlocking the Mechanism of Lecanemab: VIB-KU Leuven Researchers Identify Fc Fragment as Essential for Microglial Activation in Alzheimer’s Treatment

Rifan Muazin Mar 19, 2026 0

Researchers from the VIB-KU Leuven Center for Brain & Disease Research have published a seminal study in the journal Nature…

Read More
Laboratory Automation & Robotics

Novo Nordisk’s new weight loss treatment inferior to Lilly’s tirzepatide

Lana Keisha Mar 18, 2026 0

Novo Nordisk, a global leader in diabetes and obesity care, announced on Monday that its investigational weight loss treatment, CagriSema,…

Read More
Stem Cell & Regenerative Medicine

Researchers Create First Fully Human 3D Bone Marrow Model to Advance Cancer Treatment and Reduce Animal Testing

Dwi Wanna Mar 14, 2026 0

In a landmark development for regenerative medicine and oncology, scientists at the University of Basel and University Hospital Basel have…

Read More

Posts pagination

1 … 12 13
Sai Life Sciences Hosts Landmark Biotech Pitch Day 2026 in Boston, Forging Critical Alliances for Future Drug DiscoveryAdvanced SQL Techniques Revolutionize Data Analysis for SaaS Businesses, Unlocking Deeper Customer InsightsTWiV 1286: Clinical Update with Dr. Daniel GriffinScience News: Empowering Public Understanding of Science, Medicine, and Technology Since 1921
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ